Family Medicine · Irving, TX
NPI
1053554360
Since 2009
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
4545 Fuller Dr, Suite 325
Irving, TX, 75038
Phone (972) 870-5511
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
976 services
Medicare patients, 2024
186
Average age 71
Drug cost, 2024
$241K
2,682 prescriptions
Company payments, 2025
$17.47
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bekele C Olbamo was code 99349 (home e&m - new and established), 316 times for 131 patients. In total Bekele C Olbamo billed 976 services in 33 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99349 Home E&M - New and Established | Office | 316 | 131 | $84.98 | $27K |
| 99348 Home E&M - New and Established | Office | 251 | 122 | $51.91 | $13K |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 88 | 36 | $31.05 | $2,732 |
| 82962 Clinical Chemistry | Office | 59 | 42 | $3.21 | $189 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 47 | 47 | $126.97 | $5,968 |
| 90661 Vaccine Product | Office | 38 | 38 | $36.11 | $1,372 |
| G0008 Administration of influenza virus vaccine | Office | 37 | 37 | $31.80 | $1,177 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 32 | 29 | $35.03 | $1,121 |
| 99344 Home E&M - New and Established | Office | 18 | 18 | $103.92 | $1,871 |
By year: 2022 $170K for 2,211 services; 2023 $79K for 1,139 services; 2024 $59K for 976 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 59 | 42 | $3.21 | $189 |
Medicare prescription drug claims, 2024
In 2024, the drug Bekele C Olbamo prescribed most often to Medicare patients was Atorvastatin Calcium, with 159 prescriptions and refills. In total Bekele C Olbamo wrote 2,682 Medicare prescriptions that cost $241K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 159 | 379 | 54 | $1,644 |
| Amlodipine Besylate Generic | 117 | 328 | 40 | $1,055 |
| Furosemide Generic | 76 | 158 | 32 | $223 |
| Levothyroxine Sodium Generic | 73 | 182 | 23 | $790 |
| Carvedilol Generic | 72 | 177 | 25 | $501 |
| Metformin Hcl Generic | 70 | 129 | 17 | $476 |
| Gabapentin Generic | 68 | 140 | 26 | $2,066 |
| Pantoprazole Sodium Generic | 61 | 119 | 24 | $792 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 61 | 61 | 14 | $2,353 |
| Losartan Potassium Generic | 59 | 163 | 23 | $530 |
| Lisinopril Generic | 58 | 146 | 22 | $663 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 51 | 74 | 18 | $2,243 |
| Omeprazole Generic | 49 | 111 | 18 | $555 |
| Montelukast Sodium Generic | 46 | 65 | Under 11 | $706 |
| Trazodone Hcl Generic | 45 | 101 | 16 | $440 |
Brand drugs: 281 claims; generic drugs: 2,380 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bekele C Olbamo $17.47 ($17.47 in general payments such as food, travel and fees) from 1 company. The largest payer was Lilly USA, LLC with $17.47.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 1 | $17.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.